IRD compared with IVA: revenue, margins and what each company keeps, and the suppliers and customers both name

IRDOpus Genetics, Inc.

Mkt capRevenueRevenue

IVAInventiva S.A.

Mkt capRevenueRevenue

Compare

IRDOpus Genetics, Inc.

IVAInventiva S.A.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

IRDOpus Genetics, Inc.

3.72▲+1.23%· post 3.72· delayed

Mkt cap$305.3MRevenue$755,000Q2 FY26Revenue$14MFY25

IVAInventiva S.A.

3.81▲+4.38%· post 3.84· delayed

After hoursNov 2 '26delayed

Mkt cap$705.3MRevenue—Revenue—

Compare

After hoursNov 2 '26delayed

IRDOpus Genetics, Inc.

IVAInventiva S.A.

3.72▲+1.23%post 3.72delayed

Price

3.81▲+4.38%post 3.84delayed

$305.3M

Mkt cap

$705.3M

Q2 FY26$755,000

Revenue

—

FY25$14M

Revenue

—

IRD3.72▲+1.23%vsIVA3.81▲+4.38%After hoursNov 2 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IRD: latest quarter is a loss; flow not drawable. IVA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IRD 4

VTRSViatrissupplier

—FDA Office of Orphan Drug Productsunlistedsupplier

—Foundation Fighting Blindnessunlistedsupplier

—National Institutes of Healthunlistedsupplier

Shared 0

No shared counterparties.

Only IVA 2

—Pharmaceutical Research Associatesunlistedsupplier

—Chia Tai Tianqing Pharmaceuticalunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

IRD, solidIVA, dashed